PM
Piyush Manharlal Ajmera
About Piyush Manharlal Ajmera
Data last updated:
Piyush Manharlal Ajmera is a Director at Dpb Pharmaceuticals Limited (since 2018), Director at Vardhman Chemtech Limited (since 2021) and Director at Dpb Antibiotics Private Limited (since 2010). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹432 Cr; the largest is Dpb Pharmaceuticals Limited at ₹223 Cr (FY 2024). Earlier, Piyush Manharlal Ajmera was a Director at Kinvan Private Limited (2020–2024) and Director at Bodhitree Life Sciences Limited (from 2020) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Apr 2018 | 2018 | ₹223 Cr (FY 2024) | Active | |
| Director | 02 Feb 2021 | 1996 | ₹209 Cr (FY 2025) | Active | |
| Director | 27 Mar 2010 | 2010 | ₹10,000 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Oct 2020 | 2020 | ₹136 Cr (FY 2025) | Active | |
| Director | 24 Jul 2020 | 2020 | Strike Off | ||
| Director | 21 Nov 2009 | 2009 | ₹3.13 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Piyush Manharlal Ajmera
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavin Manharlal Ajmera | 02366882 | Dpb Pharmaceuticals Limited , Vardhman Chemtech Limited and 1 more | Director |
| Devang Manharlal Ajmera | 02366861 | Dpb Pharmaceuticals Limited , Vardhman Chemtech Limited and 1 more | Director |
| Sharvan Bhatt | 07674478 | Vardhman Chemtech Limited , Dpb Antibiotics Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Piyush Manharlal Ajmera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Piyush Manharlal Ajmera
Piyush Manharlal Ajmera currently holds 3 directorships: Dpb Pharmaceuticals Limited (Director, since 20 Apr 2018, revenue ₹223 Cr (FY 2024)); Vardhman Chemtech Limited (Director, since 02 Feb 2021, revenue ₹209 Cr (FY 2025)); Dpb Antibiotics Private Limited (Director, since 27 Mar 2010, revenue ₹10,000 (FY 2024)).
Piyush Manharlal Ajmera was first appointed on 21 Nov 2009 as Director at Parth Antibiotics Private Limited. The most recent appointment on record is 02 Feb 2021 at Vardhman Chemtech Limited.
The 3 current companies of Piyush Manharlal Ajmera that report revenue have a combined latest revenue of ₹432 Cr: Dpb Pharmaceuticals Limited ₹223 Cr (FY 2024); Vardhman Chemtech Limited ₹209 Cr (FY 2025); Dpb Antibiotics Private Limited ₹10,000 (FY 2024).
Piyush Manharlal Ajmera held 3 earlier board appointments: Kinvan Private Limited (Director, 10 Oct 2020 to 08 Aug 2024); Bodhitree Life Sciences Limited (Director, from 24 Jul 2020); Parth Antibiotics Private Limited (Director, from 21 Nov 2009).
The current boards of Piyush Manharlal Ajmera's companies include Bhavin Manharlal Ajmera (Dpb Pharmaceuticals Limited), Devang Manharlal Ajmera (Dpb Pharmaceuticals Limited), Sharvan Bhatt (Vardhman Chemtech Limited).